Relationship between HIV/Highly Active Antiretroviral Therapy (HAART)–Associated Lipodystrophy Syndrome and Stavudine‐Triphosphate Intracellular Levels in Patients with Stavudine‐Based Antiretroviral Regimens | Zendy

Peré Domingo | Zendy; Maria Carmen Cabeza | Zendy; Alain Pruvost | Zendy; Juliana Salazar | Zendy; María del Mar Gutiérrez | Zendy; María Gracia Mateo | Zendy; Joan Carles Domingo | Zendy; Irene Fernández | Zendy; Francesc Villarroya | Zendy; Jessica Muñoz | Zendy; Francesc Vidal | Zendy; Montserrat Baiget | Zendy

Open Access

Relationship between HIV/Highly Active Antiretroviral Therapy (HAART)–Associated Lipodystrophy Syndrome and Stavudine‐Triphosphate Intracellular Levels in Patients with Stavudine‐Based Antiretroviral Regimens

Author(s) -

Peré Domingo,

Maria Carmen Cabeza,

Alain Pruvost,

Juliana Salazar,

María del Mar Gutiérrez,

María Gracia Mateo,

Joan Carles Domingo,

Irene Fernández,

Francesc Villarroya,

Jessica Muñoz,

Francesc Vidal,

Montserrat Baiget

Publication year - 2010

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/651117

Subject(s) - stavudine , lipodystrophy , medicine , interquartile range , intracellular , peripheral blood mononuclear cell , reverse transcriptase inhibitor , zidovudine , immunology , gastroenterology , virology , antiretroviral therapy , biology , viral load , viral disease , virus , in vitro , biochemistry

The link between human immunodeficiency virus/highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome (HALS) and the use of thymidine analogues has been well established. However, to our knowledge, no relationship has been proven between intracellular levels of stavudine (d4T) and HALS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research